Steroid-sparing agents in the treatment of asthma.
Delaney
S G
SG
Department of Medicine, University of Otago Medical School, Dunedin, New Zealand.
Taylor
D R
DR
D001249:Asthma / Q000188:drug therapy*; D006046:Gold / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D014217:Troleandomycin / Q000009:adverse effects / Q000627:therapeutic use
D006046:Gold; D014217:Troleandomycin; D008727:Methotrexate